MDDVF (Medical Developments International) EPS without NRI: $-0.00 (TTM As of Dec. 2025)


MDDVF Medical Developments International Ltd MDDVF
51 GF Score
Price $0.37
GF Value $0.39
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Medical Developments International EPS without NRI?

Medical Developments International MDDVF 51 EPS without NRI is $-0.00 as of Dec. 2025. GuruFocus rates MDDVF with a GF Score™ of 51/100 and a GF Value™ of $0.39 (Fairly Valued). The stock has 2 warning signs investors should review. Among 784 Drug Manufacturers companies, Medical Developments International ranks worse than 127550.89% on this metric.

Medical Developments International's earnings per share without non-recurring items for the six months ended in Dec. 2025 was $-0.00. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Medical Developments International's EPS without NRI or its related term are showing as below:

During the past 13 years, Medical Developments International's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 71.00% per year. The lowest was -67.40% per year. And the median was -7.20% per year.

MDDVF's 3-Year EPS without NRI Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 9.7
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

Medical Developments International's EPS (Diluted) for the six months ended in Dec. 2025 was $-0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.00.

Medical Developments International's EPS (Basic) for the six months ended in Dec. 2025 was $-0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.00.


Medical Developments International  (OTCPK:MDDVF) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Medical Developments International EPS without NRI Related Terms


Medical Developments International EPS without NRI Historical Data

* Premium members only.

The historical data trend for Medical Developments International's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medical Developments International EPS without NRI Chart

Medical Developments International Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.05 -0.11 -0.01 -0.22 0.00

Medical Developments International Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.08 -0.23 0.00 -0.00 -0.00

MDDVF vs ZTS, UTHR: EPS without NRI Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Medical Developments International's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medical Developments International PE Ratio without NRI vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medical Developments International's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Medical Developments International's PE Ratio without NRI falls into.


MDDVF
51GF Score
Medical Developments International Ltd MDDVF
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medical Developments International EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $-0.00 mean?
Medical Developments International (MDDVF) has a EPS without NRI of $-0.00 as of Dec. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Medical Developments International and its competitors. According to the industry distribution chart, Medical Developments International ranks #999999 out of 784 companies in the Drug Manufacturers industry.
Is Medical Developments International's EPS without NRI too high?
Medical Developments International's current EPS without NRI is $-0.00. Based on the distribution chart, Medical Developments International ranks #999999 out of 784 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Medical Developments International has a GF Score™ of 51/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medical Developments International's EPS without NRI compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Medical Developments International ranks #999999 out of 784 companies for EPS without NRI. This places Medical Developments International in the lower half of its industry. The industry median EPS without NRI is 9.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Drug Manufacturers company?
The median EPS without NRI among Drug Manufacturers companies is 9.70, based on 784 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Medical Developments International and its competitors. For the Drug Manufacturers industry, the median EPS without NRI is 9.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Developments International's current EPS without NRI is $-0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Developments International stock overvalued right now?
Based on GuruFocus' analysis, Medical Developments International (MDDVF) is currently considered Fairly Valued. The stock's GF Value™ is $0.39, compared to a current price of $0.37 — trading 5.1% below its estimated fair value. The current EPS without NRI is $-0.00. Medical Developments International's overall GF Score™ is 51/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Medical Developments International (MDDVF), the current EPS without NRI is $-0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medical Developments International (MDDVF) Overvalued in 2026?

Based on GuruFocus' analysis, Medical Developments International stock appears to be undervalued. The current stock price of $0.37 is trading 5.1% below its estimated GF Value™ of $0.39. GuruFocus considers Medical Developments International to be Fairly Valued.

Key valuation signals for MDDVF:

  • EPS without NRI: $-0.00
  • GF Value™: $0.39 vs. price of $0.37 (5.1% below fair value)
  • GF Score™: 51/100 with 2 warning signs

No single metric tells the full story. See the MDDVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medical Developments International Business Description

Other Exchanges M5D:GermanyMVP:Australia
Address 4 Caribbean Drive, Scoresby, VIC, AUS, 3179
Medical Developments International Ltd is a specialized healthcare company. The Company manufactures and distributes Penthrox, a fast-acting trauma and emergency pain relief product, used in hospital emergency departments, ambulance services, sports medicine, and for analgesia during short surgical procedures. The segments of the company are Pain Management and Respiratory. The company derives maximum revenue from the Pain management segment.
51GF Score

Get the complete analysis for MDDVF

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.37
Price
$0.39
GF Value